Related Experiment Video
Updated: Feb 7, 2026

Imaging Membrane Potential with Two Types of Genetically Encoded Fluorescent Voltage Sensors
Published on: February 4, 2016
Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics
Mónica Ferreira1, Monique Beullens1, Mathieu Bollen1
1Laboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, B-3000 Leuven, Belgium.
Abstract:
Protein phosphatase 1 (PP1) catalyzes more than half of all phosphoserine/threonine dephosphorylation reactions in mammalian cells. In vivo PP1 does not exist as a free catalytic subunit but is always associated with at least one regulatory PP1-interacting protein (PIP) to generate a large set of distinct holoenzymes. Each PP1 complex controls the dephosphorylation of only a small subset of PP1 substrates. We screened the literature for genetically engineered mouse models and identified models for all PP1 isoforms and 104 PIPs. PP1 itself and at least 49 PIPs were connected to human disease-associated phenotypes. Additionally, phenotypes related to 17 PIPs were clearly linked to altered PP1 function, while such information was lacking for 32 other PIPs. We propose structural reverse genetics, which combines structural characterization of proteins with mouse genetics, to identify new PP1-related therapeutic targets. The available mouse models confirm the pleiotropic action of PP1 in health and diseases.
Insights
Protein Phosphatase 1 (PP1) and its regulatory partners control cellular dephosphorylation. Mouse models reveal PP1 complexes are crucial in human diseases, highlighting new therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Protein Phosphatase 1 (PP1) is a key enzyme in mammalian cells, responsible for over half of all phosphoserine/threonine dephosphorylation.
- PP1 functions as part of diverse holoenzymes, formed by association with regulatory PP1-interacting proteins (PIPs), each targeting specific substrates.
Purpose of the Study:
- To explore the link between PP1, PIPs, and human disease phenotypes using genetically engineered mouse models.
- To identify novel therapeutic targets for PP1-related diseases through structural reverse genetics.
Main Methods:
- Literature screening for genetically engineered mouse models of PP1 isoforms and 104 PIPs.
- Analysis of disease-associated phenotypes linked to PP1 and PIPs in mouse models.
Main Results:
- Mouse models were identified for all PP1 isoforms and 104 PIPs.
- PP1 and 49 PIPs were associated with human disease phenotypes.
- Phenotypes for 17 PIPs were directly linked to altered PP1 function, with 32 PIPs lacking this information.
Conclusions:
- PP1 holoenzymes play a pleiotropic role in both health and disease.
- Structural reverse genetics offers a promising approach to discover new therapeutic targets for PP1-related disorders.
More Related Videos
06:33Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence
Published on: July 5, 2021
18:08Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Structural Protein Function
Mechanical Protein Functions
Animal Mitochondrial Genetics